CIPO trademark

XYREM

RegisteredCIPOWord markClass 5

"XYREM" is a word mark owned by Jazz Pharmaceuticals, Inc., filed at the CIPO on July 22, 1999. It is registered and covers class 5 (Pharmaceuticals).

View Jazz Pharmaceuticals, Inc. portfolioGet this data via the API
Official CIPO record
XYREM
Word mark as filed with the CIPO
Status
Registered
Since August 6, 2002
Filed
July 22, 1999
Registered
August 6, 2002
Expires
August 6, 2032
Application no.
1023221
Registration no.
TMA565542
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns XYREM

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Jazz Pharmaceuticals, Inc.

JAZZ · United States

25 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services XYREM is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Owner Address Change / Changement d'adresse du propriétaire
  2. Amendment to Registration; Address/address
  3. Agent Changed; From: 10425 To: 32 / Voir Preuve au dossier/See evidence on File No. 1355599
  4. Renewed; DP:2017/06/14 RD:2017/06/14 RR:Ridout Maybee Ridout & Maybee LLP 11 Holland Avenue Suite 601 Ottawa, Ontario K1Y 4S1 Canada
  5. Change of Title Registered; Assignment / Voir Preuve au dossier/See evidence on File No. 1023221
  6. FROM: JPI Commercial, LLC; a Delaware limited liability company; TO: Jazz Pharmaceuticals, Inc.; Voir Preuve au dossier/See evidence on File No. 1023221
  7. Change of Title Registered; Assignment / Voir Preuve au dossier/See evidence on File No. 1023221
  8. Rep for Service Changed; From: 6489 To: 10425 / Voir Preuve au dossier/See evidence on File No. 1023221
  9. Amendment to Registration; Merger / Voir Preuve au dossier/See evidence on File No. 1023221
  10. Correspondence Created

10 earlier steps on the official record.

FAQ

About XYREM

Who owns the trademark "XYREM"?

The CIPO trademark "XYREM" (application 1023221) is owned by Jazz Pharmaceuticals, Inc.

What is the status of "XYREM"?

Its status at the CIPO is: registered.

When was "XYREM" registered?

It was registered on August 6, 2002 and is due to expire on August 6, 2032.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XYREM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019decc8-3231-77a5-9948-a20eab12b10f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019decc8-3231-77a5-9948-a20eab12b10f",
  "object": "trademark",
  "mark_text": "XYREM",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1023221",
  "filing_date": "1999-07-22",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Jazz Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70a-222a-730c-802e-638eb3dd0000"
    }
  ]
}